The Scientist

» drug development and immunology

Most Recent

image: FDA OKs siRNA Ebola Drug

FDA OKs siRNA Ebola Drug

By | September 23, 2014

The US Food and Drug Administration gives the green light to deploy an experimental short interfering RNA treatment against Ebola.

0 Comments

image: Ebola Vaccine Protects Macaques

Ebola Vaccine Protects Macaques

By | September 9, 2014

Human trials are now underway.

0 Comments

image: FDA Gives Nod to Melanoma Drug

FDA Gives Nod to Melanoma Drug

By | September 8, 2014

The US Food and Drug Administration last week approved the first of a new type of immunotherapy that aims to pit a patient’s own immune system against her cancer.

2 Comments

image: FDA to Address Female Sexual Dysfunction

FDA to Address Female Sexual Dysfunction

By | August 15, 2014

The federal agency will convene a two-day workshop in October to discuss the development of drugs to treat the issue.

0 Comments

image: Award-winning Chemist Dies

Award-winning Chemist Dies

By | July 14, 2014

Carlos Barbas III, a renowned organic chemist whose research helped in drug development, passed away at age 49. 

0 Comments

image: Done with Immunosuppressants

Done with Immunosuppressants

By | July 3, 2014

Adult sickle-cell patients have safely stopped taking their immunosuppressant medication thanks to a new type of blood stem-cell transplant.

2 Comments

image: That Loving Feeling

That Loving Feeling

By | July 1, 2014

There are no FDA-approved drugs to treat low sexual desire in women, but not for lack of trying.

1 Comment

image: FDA Approves Another New Antibiotic

FDA Approves Another New Antibiotic

By | June 24, 2014

Second new drug to treat methicillin-resistant Staphylococcus aureus approved under US Food and Drug Administration incentive program. 

1 Comment

image: Protein Clumps Spread Inflammation

Protein Clumps Spread Inflammation

By | June 22, 2014

ASC specks—protein aggregations that drive inflammation—are released from dying immune cells, expanding the reach of a defense response.

1 Comment

image: To Finish Off Polio

To Finish Off Polio

By | June 17, 2014

Along with vaccination, antiviral drugs could play a key role in the eradication of poliovirus, but it’s unclear whether today’s candidate therapies will withstand the challenges of the clinic.

0 Comments

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Grass Routes
    Features Grass Routes

    Researchers are discovering a suite of new locations and functions of endocannabinoid receptors that play roles in sickness and in health.

  3. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  4. Most of Human Genome Nonfunctional: Study
AAAS